Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Eisai
May 16, 2019
Eisai Announces Data Presentations on Oncology Pipeline, including LENVIMA® (lenvatinib) plus KEYTRUDA® (pembrolizumab) Investigational Combination Therapy at ASCO 2019
May 10, 2019
BioArctic: Alzheimer's Clinical Trials Consortium and Eisai Announce BAN2401 to be Evaluated in Clinical Study for Prevention of Alzheimer's Disease
Apr 30, 2019
Eisai and Purdue Pharma Announce Buy Out of Purdue's Rights in Worldwide Collaboration to Develop and Commercialize Lemborexant
Mar 22, 2019
Initiation Of Phase III Clinical Trial Of BAN2401 In Early Alzheimer's Disease
Mar 21, 2019
BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease
Mar 07, 2019
BioArctic: Eisai Announces Timelines for the Single Confirmatory Phase 3 Study With BAN2401 in Warly Alzheimer's Disease
Mar 06, 2019
Real World Evidence on Use of Halaven® (eribulin mesylate) Injection Following CDK 4/6 Inhibitor to be Presented at 36th Annual Miami Breast Cancer Conference
Feb 25, 2019
FDA Accepts Eisai's Supplemental New Drug Application (sNDA) to Update the Labeling for Anti-Obesity Agent BELVIQ® (lorcaserin HCl)
Feb 14, 2019
BioArctic - Full Year Report January - December 2018
Jan 07, 2019
China Mecobalamin Market Investigation Report, 2018-2022 - Indications, Sales, Competition, Manufacturers, Prices, Market Dynamics & Future Prospects
Dec 07, 2018
First Drug Candidate From Eisai-UCL Research Collaboration To Enter Alzheimer's Disease Clinical Trials
Nov 28, 2018
Eisai and METAvivor Team Up to Launch Elements as the Latest #ThisIsMBC Initiative at the 2018 San Antonio Breast Cancer Symposium
Nov 27, 2018
Eisai to Present New Research on HALAVEN® (eribulin mesylate) Injection at 41st Annual San Antonio Breast Cancer Symposium
Sep 21, 2018
Abingworth Appoints Brian Gallagher, Jr
Sep 20, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 27, 2018
Stephen Davies Appointed Vice President, Eisai Strategic Information Systems at Eisai Inc.
Aug 13, 2018
Kidney Cancer Drugs Market to 2022 By Therapeutic Class, Pharmacologic Class & Country - Key Players are Pfizer, Novartis, Bayer, Bristol-Myers Squibb, Eisai, and Exelixis
Aug 07, 2018
BioArctic Obtains Exclusive Rights to Develop Antibody Treatments for Alzheimer's Disease from a Research Project Jointly Owned with Eisai
Jul 18, 2018
BioArctic: Late Breaking Phase 2b Study Results of BAN2401 in Alzheimer's Disease Will be Webcast Live From AAIC 2018 by Eisai
Jul 18, 2018
Eisai To Present Latest Data On Alzheimer's Disease / Dementia Pipeline At Alzheimer's Association International Conference 2018
‹‹
Page 2
››
Latest News
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
Stak Mobility to Launch Second Mobility Hub in Pittsburgh; Sees Continued Momentum Across the US
Apr 25, 2024
DIC Algae Oil Sulfurized Extreme Pressure Additives Present Promising Alternatives to Lard Oils and Vegetable...
Apr 25, 2024
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment...
Apr 25, 2024
Ranpak to Hold Conference Call to Discuss First Quarter 2024 Results
Apr 25, 2024
Nodal Exchange Announces Cooperation with Deutsche Börse Market Data + Services
Apr 25, 2024
Corporate Funding for Energy Storage Sector Totaled $11.7 Billion in Q1 2024
Apr 25, 2024
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events